The omega-3 fatty acids know as EPA and DHA will be determined as nutritional value with highly effective health promoting qualities. A recent British research indicates that EPA (eicosapentaenoic acid) can have a noticeable safety effect on precancerous development in the digestive tract.
What Study Say:
Based on lab tests which had indicated that EPA has anti colon cancer activity, a research team in London, examined if EPA is capable of avoiding the development of anal polyps in human subjects who have a inherited propensity to develop intestinal melanoma. Such individuals suffer from a situation known as familial adenomatous polyposis (FAP) which predisposes them to develop intestinal polyps or precancerous growth in the intestinal. These polyps often become digestive tract or anal cancer.
A variety of 55 sufferers who had already gone through surgery to eliminate precancerous anal cancers or polyps, were arbitrarily separated into two categories. The one team was given 2 gram of EPA on a regular basis for 6 months, while the other team obtained a placebo (dummy pill. Endoscopies were conducted on all the subjects before and after the 6 several weeks of therapy to determine if any changes had happened in their tendency to generate colon polyps. Samples of intestinal cells were also evaluated for omega-3 content.
What Result Found:
The sufferers getting the EPA complement on a regular basis experienced an impressive decrease of 22.4% in the variety of new polyps that had developed over 6 months and a 30% decrease in the size of their colorectal polyps. In comparison, the situation of the sufferers in the team getting placebo had worsened with a rise in both the variety and size of the colorectal polyps. In the treatment group, the EPA supplementation also caused a positive 2.6-fold increase in the EPA-levels in bowel tissue compared to the placebo-treated group. Because a new form of concentrated EPA in what is called "an enteric-coated formulation" was used for this study (i.e. tablets coated in such a way that they are only digested in the intestine and not in the stomach), the patients found that they did not experience indigestion which is often associated with taking omega-3 supplements.
What Study Say:
Based on lab tests which had indicated that EPA has anti colon cancer activity, a research team in London, examined if EPA is capable of avoiding the development of anal polyps in human subjects who have a inherited propensity to develop intestinal melanoma. Such individuals suffer from a situation known as familial adenomatous polyposis (FAP) which predisposes them to develop intestinal polyps or precancerous growth in the intestinal. These polyps often become digestive tract or anal cancer.
A variety of 55 sufferers who had already gone through surgery to eliminate precancerous anal cancers or polyps, were arbitrarily separated into two categories. The one team was given 2 gram of EPA on a regular basis for 6 months, while the other team obtained a placebo (dummy pill. Endoscopies were conducted on all the subjects before and after the 6 several weeks of therapy to determine if any changes had happened in their tendency to generate colon polyps. Samples of intestinal cells were also evaluated for omega-3 content.
What Result Found:
The sufferers getting the EPA complement on a regular basis experienced an impressive decrease of 22.4% in the variety of new polyps that had developed over 6 months and a 30% decrease in the size of their colorectal polyps. In comparison, the situation of the sufferers in the team getting placebo had worsened with a rise in both the variety and size of the colorectal polyps. In the treatment group, the EPA supplementation also caused a positive 2.6-fold increase in the EPA-levels in bowel tissue compared to the placebo-treated group. Because a new form of concentrated EPA in what is called "an enteric-coated formulation" was used for this study (i.e. tablets coated in such a way that they are only digested in the intestine and not in the stomach), the patients found that they did not experience indigestion which is often associated with taking omega-3 supplements.
No comments:
Post a Comment